AZD2014 and Weekly Paclitaxel in Squamous NSCLC

PHASE2TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 15, 2015

Primary Completion Date

December 29, 2016

Study Completion Date

December 29, 2016

Conditions
Squamous Non Small Cell Lung Cancer
Interventions
DRUG

Open-label AZD2014

Dual TORC1/TORC2 inhibitor

DRUG

paclitaxel

Taxane

Trial Locations (7)

17007

Research Site, Girona

17022

Research Site, Hershey

48201

Research Site, Detroit

75251

Research Site, Dallas

82131

Research Site, Gauting

02215

Research Site, Boston

08035

Research Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY